These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12496046)
1. Do thyroid disorders increase the risk of breast cancer? Simon MS; Tang MT; Bernstein L; Norman SA; Weiss L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone K; Marchbanks PA; McDonald JA; Strom BL; Wilson HG; Spirtas R Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1574-8. PubMed ID: 12496046 [TBL] [Abstract][Full Text] [Related]
2. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women. Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436 [TBL] [Abstract][Full Text] [Related]
3. Risk of breast cancer associated with short-term use of oral contraceptives. Folger SG; Marchbanks PA; McDonald JA; Bernstein L; Ursin G; Berlin JA; Daling JR; Norman SA; Strom BL; Weiss LK; Simon MS; Burkman RT; Malone KE; Spirtas R Cancer Causes Control; 2007 Mar; 18(2):189-98. PubMed ID: 17216547 [TBL] [Abstract][Full Text] [Related]
4. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer. Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738 [TBL] [Abstract][Full Text] [Related]
5. Anthropometry and the risk of epithelial ovarian cancer. Greer JB; Modugno F; Ness RB; Allen GO Cancer; 2006 May; 106(10):2247-57. PubMed ID: 16596653 [TBL] [Abstract][Full Text] [Related]
6. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA; J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216 [TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone and breast carcinoma. Primary hypothyroidism is associated with a reduced incidence of primary breast carcinoma. Cristofanilli M; Yamamura Y; Kau SW; Bevers T; Strom S; Patangan M; Hsu L; Krishnamurthy S; Theriault RL; Hortobagyi GN Cancer; 2005 Mar; 103(6):1122-8. PubMed ID: 15712375 [TBL] [Abstract][Full Text] [Related]
8. Lifetime physical activity and the risk of breast cancer: a case-control study. Kruk J Cancer Detect Prev; 2007; 31(1):18-28. PubMed ID: 17296272 [TBL] [Abstract][Full Text] [Related]
9. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones. Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882 [TBL] [Abstract][Full Text] [Related]
10. Tonsillectomy and breast cancer risk in the Western New York Diet Study. Brasky TM; Bonner MR; Dorn J; Marhsall JR; Vena JE; Brasure JR; Freudenheim JL Cancer Causes Control; 2009 Apr; 20(3):369-74. PubMed ID: 18953693 [TBL] [Abstract][Full Text] [Related]
11. Cigarette smoking and risk of breast carcinoma in situ. Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252 [TBL] [Abstract][Full Text] [Related]
12. Ovarian cysts and breast cancer: results from the Women's Contraceptive and Reproductive Experiences Study. Knight JA; Lesosky M; Blackmore KM; Voigt LF; Holt VL; Bernstein L; Marchbanks PA; Burkman RT; Daling JR; Whittemore AS Breast Cancer Res Treat; 2008 May; 109(1):157-64. PubMed ID: 17616808 [TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-treated breast carcinoma patients and the risk of acute myocardial infarction and newly-diagnosed angina. Bradbury BD; Lash TL; Kaye JA; Jick SS Cancer; 2005 Mar; 103(6):1114-21. PubMed ID: 15712362 [TBL] [Abstract][Full Text] [Related]
14. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer. Tworoger SS; Eliassen AH; Sluss P; Hankinson SE J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279 [TBL] [Abstract][Full Text] [Related]
15. Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer. Strom BL; Berlin JA; Weber AL; Norman SA; Bernstein L; Burkman RT; Daling JR; Deapen D; Folger SG; Malone KE; Marchbanks PA; Simon MS; Ursin G; Weiss LK; Spirtas R Contraception; 2004 May; 69(5):353-60. PubMed ID: 15105056 [TBL] [Abstract][Full Text] [Related]
16. Cadmium exposure and breast cancer risk. McElroy JA; Shafer MM; Trentham-Dietz A; Hampton JM; Newcomb PA J Natl Cancer Inst; 2006 Jun; 98(12):869-73. PubMed ID: 16788160 [TBL] [Abstract][Full Text] [Related]
17. Urinary melatonin levels and breast cancer risk. Schernhammer ES; Hankinson SE J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307 [TBL] [Abstract][Full Text] [Related]
18. Reproductive and menstrual history and papillary thyroid cancer risk: the San Francisco Bay Area thyroid cancer study. Sakoda LC; Horn-Ross PL Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):51-7. PubMed ID: 11815401 [TBL] [Abstract][Full Text] [Related]
19. Effect of reproductive factors and oral contraceptives on breast cancer risk in BRCA1/2 mutation carriers and noncarriers: results from a population-based study. Lee E; Ma H; McKean-Cowdin R; Van Den Berg D; Bernstein L; Henderson BE; Ursin G Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):3170-8. PubMed ID: 18990759 [TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women. Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]